DSB-1559

N/A

Report date: 2024/07/12 09:36:05

NME

Base Information

Drug NameDSB-1559

Drug Alias NameDSB-1559

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors

TargetsPoly (ADP-Ribose) polymerase 1

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDuke Street Bio Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A